Literature DB >> 7215949

Factors affecting the healing rate of duodenal and pyloric ulcers with low-dose antacid treatment.

S Massarrat, A Eisenmann.   

Abstract

In 80 patients with duodenal ulcer, the effects of various factors--symptoms, endoscopic findings, and peak acid output (PAO)--on the healing rate were studied during eight weeks of outpatient therapy with low-dose antacid (neutralising capacity less than 50 mmol HCl/d). Fifty-six per cent of the ulcers healed. The following unfavourable factors were found to cause a significant delay in ulcer healing: a long duration of pain in the last ulcer relapse and the present period of ulcer pain, smoking, stenosis of the duodenal bulb, and a high PAO. Multiple regression analysis showed that three factors (duration of the present ulcer pain, smoking, and stenosis of the duodenum) had a significant influence on healing rate. According to the results obtained with this method, the patients with no or only one unfavourable factor (n = 35) had the best healing rate: 80%, compared with patients who had two (n = 31) or three (n = 14) unfavourable factors. The healing rate of the latter two groups was 41% and 28%, respectively (p less than 0.001). A prognostic score based on these three factors represents the severity of duodenal-ulcer disease with regard to the healing process under placebo-like doses of antacid.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7215949      PMCID: PMC1419232          DOI: 10.1136/gut.22.2.97

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Healing of duodenal ulcer with an antacid regimen.

Authors:  W L Peterson; R A Sturdevant; H D Frankl; C T Richardson; J I Isenberg; J D Elashoff; J Q Sones; R A Gross; R W McCallum; J S Fordtran
Journal:  N Engl J Med       Date:  1977-08-18       Impact factor: 91.245

2.  [Treatment of duodenal and gastric ulcer with cimetidine. A multicenter double-blind trial (author's transl)].

Authors:  R Lambert; J P Bader; J J Bernier; J Bertrand; C Bétourné; J Gastard; C Laverdant; A Ribet; J Sahel; J Toulet
Journal:  Gastroenterol Clin Biol       Date:  1977

3.  Antacids vs placebos in peptic ulcer therapy. A controlled double-blind investigation.

Authors:  D Hollander; J Harlan
Journal:  JAMA       Date:  1973-12-03       Impact factor: 56.272

4.  The Veterans Administration Cooperative Study on Gastric Ulcer. 3. Site and size of the ulcer as determinants of outcome.

Authors:  D C Sun; S J Stempien
Journal:  Gastroenterology       Date:  1971-10       Impact factor: 22.682

5.  Histamine H2-receptor antagonists in the treatment of duodenal ulcers.

Authors:  S Bank; G O Barbezat; B H Novis; L O Tim; H S Odes; C Helman; L Narunsky; P J Duys; I N Marks
Journal:  S Afr Med J       Date:  1976-10-16

6.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

7.  Studies on factors affecting healing of gastric ulcer. A prospective, cooperative study in Japan.

Authors:  T Nakajima
Journal:  Am J Gastroenterol       Date:  1976-08       Impact factor: 10.864

8.  Gastric and duodenal ulcer healing under placebo treatment.

Authors:  U Scheurer; L Witzel; F Halter; H M Keller; R Huber; R Galeazzi
Journal:  Gastroenterology       Date:  1977-05       Impact factor: 22.682

9.  Cimetidine in the treatment of active duodenal and prepyloric ulcers.

Authors:  G Bodemar; A Walan
Journal:  Lancet       Date:  1976-07-24       Impact factor: 79.321

10.  Cimetidine in duodenal ulcer. Controlled trial.

Authors:  W S Blackwood; D P Maudgal; R G Pickard; D Lawrence; T C Northfield
Journal:  Lancet       Date:  1976-07-24       Impact factor: 79.321

View more
  20 in total

1.  Does treatment of Helicobacter pylori with antibiotics alone heal duodenal ulcer? A randomised double blind placebo controlled study.

Authors:  S K Lam; C K Ching; K C Lai; B C Wong; C L Lai; C K Chan; L Ong
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

2.  Gastric emptying of two radiolabelled antacids.

Authors:  J Monés; I Carrió; M Roca; M Estorch; R Calabuig; S Sainz; C Martinez-Duncker; F Vilardell
Journal:  Gut       Date:  1991-02       Impact factor: 23.059

3.  A comparison of roxatidine acetate and ranitidine in gastric ulcer healing.

Authors:  G Judmaier
Journal:  Drugs       Date:  1988       Impact factor: 9.546

4.  Increased gastric secretory capacity in smokers without gastrointestinal lesions.

Authors:  S Massarrat; F Enschai; P M Pittner
Journal:  Gut       Date:  1986-04       Impact factor: 23.059

5.  Prostaglandin E1 (misoprostol) overcomes the adverse effect of chronic cigarette smoking on duodenal ulcer healing.

Authors:  S K Lam; W Y Lau; T K Choi; C L Lai; A S Lok; W M Hui; M M Ng; S K Choi
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

6.  The refractory ulcer.

Authors:  D W Piper
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

7.  Markers of slow-healing peptic ulcer in the elderly. A study on 1,052 ranitidine-treated patients.

Authors:  G Battaglia; F Di Mario; P Dotto; G Leandro; A Pilotto; M Ferrana; F Vianello; S Vigneri; C V Colonna; R Naccarato
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

8.  Refractory duodenal ulcer.

Authors:  K D Bardhan
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

9.  Factors influencing the healing rate of gastric ulcer in hospitalised subjects.

Authors:  M Okada; T Yao; T Fuchigami; K Imamura; T Omae
Journal:  Gut       Date:  1984-08       Impact factor: 23.059

Review 10.  Prescribing policy for antiulcer treatment in the elderly.

Authors:  G Bianchi Porro; M Lazzaroni
Journal:  Drugs Aging       Date:  1993 Jul-Aug       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.